WASHINGTON — Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C. Scott released the following statement on the Department of Health and Human Services’ proposal requiring drug companies to disclose the list price of prescription drugs in television ads:
“We share the Administration’s goal of reducing prescription drug prices. Pharmacy benefit managers (PBMs) foster competition among drugmakers, resulting in lower costs for consumers.
We believe that list prices of drugs should be included in drug manufacturers’ communications with prescribers to help patients make informed treatment choices.
The most direct way to reduce costs and improve access to prescription drugs is for drugmakers to cut their prices, and we look forward to working with the Administration and Congress to accomplish this goal.”
PCMA issues statement on proposal requiring list prices of drugs in TV ads
Pharmaceutical Care Management Association (PCMA) president and chief executive officer J.C.
Latest
FDA approves TYLENOL with Naproxen
FDA-approved first and only OTC fixed‑dose combination of acetaminophen and naproxen sodium, expanding non-opioid options for persistent pain.
Quick commerce gains ground in healthcare
"The implications are far reaching," said Katherine Black, a Kearney partner and the report's author.
Future Beauty Brands appoints Heather Wallace CEO
Wallace succeeds Rob Keen and brings more than 20 years of experience in beauty and consumer health.
Walgreens opening new location on Long Island's East End
New store marks a key step in the community and ensures access to essential pharmacy and retail services for residents.